The world's first personalised mRNA cancer jab for melanoma is being tested on British patients. Steve Young, 52, from Stevenage, joined a clinical trial after being diagnosed with the potentially deadly form of skin cancer. Dr Heather Shaw, an investigator for the trial, said the jab had the potential to cure people with melanoma and is being tested in other cancers.
“This is one of the most exciting things we’ve seen in a really long time," she said.
Report by Kennedyl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
“This is one of the most exciting things we’ve seen in a really long time," she said.
Report by Kennedyl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Category
🗞
NewsTranscript
00:00 We're just in the process of rolling out the sites in the UK.
00:04 So we've got several sites in rolling patients in the UK just now.
00:07 And so we've got the beginnings of our cohort of patients coming online.
00:12 And so there will be more as we go forward through the study.
00:15 So at the moment, this is just getting started in the UK.
00:18 We've been running since about November in some centres,
00:21 with other centres coming online all the way through till very recently.
00:25 And so we've not we've not got lots and lots of that 900 patients
00:29 on in the UK yet, but we've got and we're, you know, we're in the tens,
00:33 but we're coming up.
00:34 I mean, this is a real revolution in cancer therapy.
00:39 This is something that we've never really been able to do before at scale
00:42 to think about producing a product that's personal to the patient
00:47 that targets their cancer specifically and might help them
00:51 through their pathway with fewer, you know, with no
00:54 potentially no added extra side effects from the treatment,
00:58 but still getting extra benefit from what they're doing.